Page 72 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 72

Chapter 3
                                                    70
Table 2. Results of HLA typing in 32 women with high-grade CIN
Case Regression
HPV geno- typing (HPV 16
or other)
HLA-A* HLA-A*
HLA-B* HLA-B* HLA-C* HLA-C*
HLA- HLA- HLA- HLA- HLA- HLA- HLA- HLA- DRB1* DRB1* DRB3/4/5* DRB3/4/5* DQA* DQA* DQB* DQB*
159 No 161 Yes 164 No 170 No 171 No 182 No 186 No 187 Yes 189 No 191 No 192 Yes 194 Yes 197 Yes 200 Yes 203 No 204 No 206 Yes 207 Yes 208 Yes 218 No 221 No 222 Yes 223 No
02 -a
Xb X
02 11
02 25
03 31
02 294044 03 01 02 08 15 03
HPV16
OTHER
HPV16
HPV16
HPV16
HPV16
HPV16
OTHER 02 OTHER 01 OTHER 03 HPV16 02 OTHER 01 OTHER 01 OTHER 02 OTHER 01 OTHER 01 HPV16 02 HPV16 03 HPV16 03 OTHER 02 OTHER 01 HPV16 02 OTHER 01
40 44 03 05 X X 07
15 - 03 04 07 18 07 12 15 44 03 07
04 12 3*02 03 15 3*01 04 - 4*01 01 15 5*01 04 08 4*01
4*01 03 05 03 - 5*01 01 05 02 06 - 03 -X X
33 18 35 04
020744 07
25071807
68 08 35 04
02 08 35 04
03 07 44 05
-4044 03
02 07 15 07
02 08 15 03
25071807
30 07 - 07
31 X X X X 04 15 4*01
3*02 05 - 03 -
- 02 03 02 03 - 01 - 06 - 5*01 01 03 03 06 3*02 05 - 02 03 5*01 01 05 02 06 - 01 05 02 06 4*01 03 05 03 - 4*01 03 05 02 03 - 01 - 06 - 5*01 01 02 02 06 5*01 01 03 03 06 3*02 05 03
5*01 01 05 02 06 4*01 03 05 03 -
33183504
02 08 51 07
- 40 49 03 07 04 11 3*02 02 14 35 04 08 01 13 3*03
16 01 07 4*01 07 03 04 3*01 07 11 13 3*01 16 04 07 4*01 1215-5*01 07 04 15 4*01 07 03 11 3*01 07 03 15 3*01 07 03 13 3*01 - 04 11 3*02 07 03 04 3*01 1215-5*01 - 07 15 4*01
01 02 02 05 4*01 03 05 02 03
07 11 13 3*01 14 03 15 3*01
01 -05 06 - 03 06 03 -
01 -0506
table continues















































   70   71   72   73   74